Genome and Functional Characterization of Colonization Factor Antigen I- and CS6-Encoding Heat-Stable Enterotoxin-Only Enterotoxigenic

Escherichia coli comparative genomics heat-stable toxin

Journal

mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636

Informations de publication

Date de publication:
Historique:
received: 17 12 2018
accepted: 17 12 2018
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 5 4 2019
Statut: epublish

Résumé

Enterotoxigenic Escherichia coli (ETEC) is a significant cause of childhood diarrhea and is a leading cause of traveler's diarrhea. ETEC strains encoding the heat-stable enterotoxin (ST) are more often associated with childhood diarrhea than ETEC strains that encode only the heat-labile enterotoxin (LT). Colonization factors (CFs) also have a demonstrated role in ETEC virulence, and two of the most prevalent CFs among ETEC that have caused diarrhea are colonization factor antigen I (CFA/I) and CS6. In the current report, we describe the genomes of 269 CS6- or CFA/I-encoding ST-only ETEC isolates that were associated with human diarrhea. While the CS6 and CFA/I ETEC were identified in at least 13 different ETEC genomic lineages, a majority (85%; 229/269) were identified in only six lineages. Complete genome sequencing of selected isolates demonstrated that a conserved plasmid contributed to the dissemination of CFA/I whereas at least five distinct plasmids were involved in the dissemination of ST and/or CS6. Additionally, there were differences in gene content between CFA/I and CS6 ETEC at the phylogroup and lineage levels and in association with their geographic location of isolation as well as lineage-related differences in ST production. Thus, we demonstrate that genomically diverse E. coli strains have acquired ST, as well as CFA/I or CS6, via one or more plasmids and that, in some cases, isolates of a particular lineage or geographic location have undergone additional modifications to their genome content. These findings will aid investigations of virulence and the development of improved diagnostics and vaccines against this important human diarrheal pathogen.

Identifiants

pubmed: 30944874
doi: 10.1128/mSystems.00329-18
pii: mSystems00329-18
pmc: PMC6446980
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI125542
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109776
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI110820
Pays : United States

Références

Vaccine. 1999 Aug 20;18(1-2):38-49
pubmed: 10501233
J Clin Microbiol. 2000 Jan;38(1):27-31
pubmed: 10618058
J Infect Dis. 2002 Dec 15;186(12):1740-7
pubmed: 12447759
Infect Immun. 2004 Mar;72(3):1786-94
pubmed: 14977988
Nat Rev Microbiol. 2004 Feb;2(2):123-40
pubmed: 15040260
Infect Immun. 1977 Mar;15(3):781-8
pubmed: 15947
Clin Microbiol Rev. 2005 Jul;18(3):465-83
pubmed: 16020685
Infect Immun. 2006 Apr;74(4):2245-58
pubmed: 16552055
Mol Microbiol. 2006 Jun;60(5):1136-51
pubmed: 16689791
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
J Bacteriol. 2008 Oct;190(20):6881-93
pubmed: 18676672
Microbiol Mol Biol Rev. 2009 Dec;73(4):750-74
pubmed: 19946140
Bioinformatics. 2010 Jun 15;26(12):1488-92
pubmed: 20413634
J Bacteriol. 2010 Nov;192(21):5822-31
pubmed: 20802035
Infect Immun. 2011 Feb;79(2):950-60
pubmed: 21078854
J Clin Microbiol. 2011 Apr;49(4):1403-10
pubmed: 21289147
Vaccine. 2011 Aug 11;29(35):5869-85
pubmed: 21616116
J Infect Dis. 2011 Jul 1;204(1):60-4
pubmed: 21628659
Stand Genomic Sci. 2011 Apr 29;4(2):244-51
pubmed: 21677861
J Clin Microbiol. 2011 Sep;49(9):3198-203
pubmed: 21775541
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Clin Vaccine Immunol. 2012 Dec;19(12):1921-31
pubmed: 23035175
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45
pubmed: 23169936
Clin Infect Dis. 2012 Dec;55 Suppl 4:S294-302
pubmed: 23169941
J Clin Microbiol. 2013 Feb;51(2):633-5
pubmed: 23224092
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Plasmid. 2013 Nov;70(3):343-52
pubmed: 23933356
Clin Microbiol Rev. 2013 Oct;26(4):822-80
pubmed: 24092857
PeerJ. 2014 Apr 01;2:e332
pubmed: 24749011
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
BMC Infect Dis. 2014 Sep 04;14:482
pubmed: 25190096
Nat Genet. 2014 Dec;46(12):1321-6
pubmed: 25383970
Vaccine. 2014 Dec 12;32(52):7077-84
pubmed: 25444830
J Clin Microbiol. 2015 Aug;53(8):2410-26
pubmed: 25972421
MBio. 2015 Jun 09;6(3):e00501
pubmed: 26060273
Infect Immun. 2015 Oct;83(10):4103-17
pubmed: 26238712
Vaccine. 2016 Jun 3;34(26):2880-2886
pubmed: 26988259
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Int J Med Microbiol. 2016 Nov;306(7):586-594
pubmed: 27350142
Nat Microbiol. 2016 Jan 18;1:15014
pubmed: 27571975
EcoSal Plus. 2016 Oct;7(1):
pubmed: 27735786
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Infect Genet Evol. 2017 Aug;52:26-29
pubmed: 28442437
Sci Rep. 2017 Jun 13;7(1):3402
pubmed: 28611468
Sci Rep. 2017 Jun 14;7(1):3513
pubmed: 28615618
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674052
Sci Rep. 2018 Jul 6;8(1):10291
pubmed: 29980699
PLoS Negl Trop Dis. 2019 Jan 4;13(1):e0007037
pubmed: 30608930
Infect Immun. 1977 Jul;17(1):78-82
pubmed: 328397
Infect Immun. 1978 Mar;19(3):1021-30
pubmed: 346481
Infect Immun. 1986 Feb;51(2):626-30
pubmed: 3510984
Infect Immun. 1979 Mar;23(3):729-36
pubmed: 378834
Appl Microbiol. 1972 Jul;24(1):127-31
pubmed: 4560465
Lancet. 1975 Aug 9;2(7928):239-41
pubmed: 49793
J Infect Dis. 1980 Jun;141(6):733-7
pubmed: 6104683
J Bacteriol. 1983 Jan;153(1):566-70
pubmed: 6336743
Mol Microbiol. 1995 Jul;17(1):123-35
pubmed: 7476198
Mol Microbiol. 1994 Apr;12(1):71-82
pubmed: 7914665
Infect Immun. 1994 Aug;62(8):3463-71
pubmed: 8039917
Trends Microbiol. 1996 Nov;4(11):444-52
pubmed: 8950814
Gene. 1997 Jun 11;192(1):39-43
pubmed: 9224872
Clin Microbiol Rev. 1998 Jan;11(1):142-201
pubmed: 9457432

Auteurs

Tracy H Hazen (TH)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Sushma Nagaraj (S)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Sunil Sen (S)

Center for Vaccine Development, Institute for Global Health and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Jasnehta Permala-Booth (J)

Center for Vaccine Development, Institute for Global Health and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Felipe Del Canto (F)

Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Roberto Vidal (R)

Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Instituto Milenio de Inmunología e Inmunoterapia, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Eileen M Barry (EM)

Center for Vaccine Development, Institute for Global Health and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Jacob P Bitoun (JP)

Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.

Wilbur H Chen (WH)

Center for Vaccine Development, Institute for Global Health and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Sharon M Tennant (SM)

Center for Vaccine Development, Institute for Global Health and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

David A Rasko (DA)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Classifications MeSH